Tbi-1501
Lymphoblastic Leukemia, Acute Adult
Takara Bio Inc.Phase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
73 Active assets in the Lymphoblastic Leukemia, Acute Adult cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
MERCAPTOPURINE ANHYDROUS Shanxi Bethune Hospital | Phase 4 | A |
Cyclophosphamide The First Affiliated Hospital of Zhengzhou University | Phase 4 | BBB |
DEXAMETHASONE Shanxi Bethune Hospital | Phase 4 | BBB |
METHOTREXATE PETHEMA Foundation | Phase 4 | BBB |
Cytosin-Arabinosid PETHEMA Foundation | Phase 4 | BBB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →